09/05/2017
10/25/2016
SAPHENEIA USA CELEBRATES ITS 10th ANNIVERSARY
09/01/2016
SAPHENEIA USA EXPANDS INTO NEW OFFICE SPACE IN COLORADO
3/26/2015
SAPHENEIA ANNOUNCES INTERNATIONAL CLOUD BASED RESEARCH LAB
01/12/2015
SAPHENEIA / SCANNERSIDE SIGNS MAJOR AGREEMENT WITH BC TECHNICAL
DENVER--(BUSINESS WIRE)--Sapheneia-Scannerside and BC Technical have formed a partnership to address Legislation and Patient Awareness that has reached a turning point in the U.S. radiology industry. This proactive move comes at a time when XR-29, CMS Lung Screening, and other regulations are starting to go into effect and impact medical reimbursements for imaging.
12/17/2014
SAPHENEIA / SCANNERSIDE RELEASE REVOLUTIONARY LUNG SCREENING SOFTWARE
DENVER, Colo., USA –Less than 30 days after the Sapheneia Scannerside partnership announcement, the two companies bring the first single-source solution for CMS Lung Screening, ClearCT™ Lung to market.
On November 10, 2014, the U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening for Medicare recipients. Part of the radiology imaging center eligibility criteria include Low Dose Computed Tomography (LDCT) of less than1.5 mSv and the collection and submission of data to a CMS-approved national registry. ClearCT Lung provides a simple and affordable solution for radiology imaging centers to meet these criteria.
12/1/2014
SAPHENEIA, INC. AND SCANNERSIDE JOIN FORCES TO OFFER THE BEST VALUE FOR DOSE TRACKING AND DOSE REDUCTION IN RADIOLOGY
DENVER, Colo., USA –Sapheneia, Inc., a global medical software developer, has partnered with Scannerside to provide a Comprehensive Dose Strategy (CDS) to the medical imaging industry.
The CDS monitors dose, optimizes image protocols, reduces dose with ClearCT™ and includes XR-29 software upgrade options. This process also includes a patient awareness program, DoseCard™, along with community outreach and education materials.
7/31/2014
SAPHENEIA WINS THE FINAL TWO CASES AT APPEALS COURT WHICH COMPLETES ALL LITIGATION WITH CONTEXTVISION
DILLON, Colorado USA – July 31, 2014 – Management of Sapheneia LLC and Sapheneia Commercial Products AB wins the final two cases in Swedish Appeals Court. Sapheneia was represented by Setterwalls, one of Sweden’s leading full service law firms which had previously won all lower court decisions for Sapheneia.
ContextVision’s 2014 Q2 Reports states, “All legal processes related to Sapheneia and individuals linked to the company have finally come to an end.”
6/2/2014
SAPHENEIA, INC. COMPLETES INITIAL PHASE OF ITS CORPORATE RECAPITALIZATION
1/8/2014
SAINT PETE MRI BRINGS SAPHENEIA DOSE REDUCTION TECHNOLOGY TO THE GREATER TAMPA/ST. PETERSBURG METROPOLITAN AREA
9/20/2013
SAPHENEIA, INC. SIGNS AGREEMENT WITH PREMIER HEALTHCARE ALLIANCE
9/17/2013
SAPHENEIA, INC. LOOKS TO CONTINUE STRONG SALES THROUGH Q4: NEW PRODUCT LAUNCHES, OEM CONTRACTS ON TRACK TO CLOSE
9/17/2013
SAPHENEIA, INC. NAMES NEW CEO: STASHICK BRINGS ORGANIZATIONAL DEVELOPMENT, FINANCIAL EXPERTISE TO MEDICAL SOFTWARE COMPANY
5/27/2013
SWISS UNIVERSITY HOSPITAL PIONEERS SAPHENEIA'S CLARITY SOLUTION NM FOR LOW-DOSE SPECT/CT APPLICATIONS
11/23/2012
SAPHENEIA IMPLEMENTS CLARITY™ CT DOSE REDUCTION AND IMAGE OPTIMIZATION SOLUTION IN SIX PREMIER RADIOLOGY CENTERS IN NORTHERN CALIFORNIA. FACILITIES ACHIEVE CT DOSE REDUCTION AS MUCH AS 50%
6/1/2012
SAPHENEIA UPDATES CLARITY™ ULTRASOUND OEM
